AiCuris' AiCubator: Opportunities for innovations from North Rhine-Westphalia
AiCuris is opening the doors of its AiCubator program to young research projects and start-ups focusing on groundbreaking treatments for viral infections in immunocompromised patients. The company, based in Wuppertal, North Rhine-Westphalia, is a leader in the development of drugs to combat serious infectious diseases.
What does the AiCubator offer?
- First-hand support: The AiCubator supports selected projects with scientific know-how and expertise in drug development for up to three years.
- Network and partnerships: Participants in the program gain access to AiCuris' international network, which includes renowned scientific partners, pharmaceutical and biotechnology companies.
- Application and details: Interested individuals can apply for the program using the AiCubator application form. More information and the necessary documents are available directly on the AiCubator website.
Key data and timetable
- Application period: October 1st to December 31st, 2023
- Announcement of the winning projects: April 2024
The initiative represents a first-class opportunity for research groups and biotech start-ups from North Rhine-Westphalia and beyond to take their research and innovations to a new level.
Source: BIO.NRW; AiCuris
